| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Receptors, Urokinase Plasminogen Activator | 8 | 2020 | 252 | 2.05 | Why? |
| Injections, Spinal | 7 | 2018 | 61 | 1.15 | Why? |
| Coronary Artery Disease | 8 | 2018 | 2570 | 0.84 | Why? |
| Integrin alphaVbeta3 | 1 | 2017 | 16 | 0.70 | Why? |
| Infusion Pumps, Implantable | 3 | 2018 | 31 | 0.69 | Why? |
| Spinal Cord Stimulation | 4 | 2017 | 25 | 0.69 | Why? |
| Apolipoproteins | 1 | 2017 | 33 | 0.69 | Why? |
| Stem Cells | 4 | 2018 | 595 | 0.68 | Why? |
| Angina Pectoris | 2 | 2018 | 114 | 0.66 | Why? |
| Podocytes | 1 | 2017 | 82 | 0.65 | Why? |
| Heart Arrest | 3 | 2021 | 1239 | 0.60 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.60 | Why? |
| Attitude to Death | 1 | 2019 | 307 | 0.59 | Why? |
| Aortic Valve Insufficiency | 1 | 2017 | 136 | 0.59 | Why? |
| Cardiology | 3 | 2019 | 2873 | 0.57 | Why? |
| Aortic Valve Stenosis | 3 | 2018 | 741 | 0.56 | Why? |
| Grief | 1 | 2019 | 320 | 0.55 | Why? |
| Chronic Pain | 4 | 2020 | 736 | 0.54 | Why? |
| Transcatheter Aortic Valve Replacement | 3 | 2018 | 839 | 0.54 | Why? |
| Cell Movement | 2 | 2018 | 695 | 0.52 | Why? |
| Proteinuria | 1 | 2017 | 474 | 0.52 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.52 | Why? |
| Heart Valve Prosthesis Implantation | 2 | 2017 | 552 | 0.51 | Why? |
| Echocardiography, Transesophageal | 1 | 2017 | 447 | 0.51 | Why? |
| African Americans | 6 | 2021 | 3363 | 0.51 | Why? |
| Analgesics | 4 | 2017 | 451 | 0.49 | Why? |
| Lipids | 1 | 2016 | 1079 | 0.39 | Why? |
| Renal Insufficiency, Chronic | 3 | 2018 | 2654 | 0.37 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2021 | 1876 | 0.35 | Why? |
| Drug Delivery Systems | 4 | 2018 | 1365 | 0.33 | Why? |
| Analgesics, Opioid | 2 | 2020 | 1070 | 0.33 | Why? |
| C-Reactive Protein | 3 | 2018 | 7972 | 0.33 | Why? |
| Endothelial Progenitor Cells | 2 | 2018 | 103 | 0.33 | Why? |
| Depressive Disorder | 1 | 2016 | 1236 | 0.30 | Why? |
| Georgia | 6 | 2018 | 955 | 0.30 | Why? |
| Hospital Mortality | 9 | 2021 | 22087 | 0.30 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2020 | 6166 | 0.25 | Why? |
| Cardiovascular Diseases | 6 | 2020 | 11497 | 0.25 | Why? |
| Cell Count | 3 | 2018 | 228 | 0.24 | Why? |
| Failed Back Surgery Syndrome | 2 | 2017 | 4 | 0.23 | Why? |
| Medical Oncology | 1 | 2018 | 3826 | 0.23 | Why? |
| Surgical Wound Infection | 2 | 2017 | 501 | 0.23 | Why? |
| Medical Futility | 1 | 2021 | 150 | 0.21 | Why? |
| Electrodes, Implanted | 2 | 2017 | 60 | 0.21 | Why? |
| Pain Management | 2 | 2020 | 854 | 0.21 | Why? |
| Physicians | 1 | 2019 | 4214 | 0.20 | Why? |
| Resuscitation Orders | 1 | 2021 | 188 | 0.20 | Why? |
| Troponin I | 2 | 2018 | 1298 | 0.19 | Why? |
| Hydromorphone | 1 | 2017 | 20 | 0.18 | Why? |
| Bupivacaine | 1 | 2017 | 24 | 0.18 | Why? |
| Cohort Studies | 11 | 2021 | 36005 | 0.18 | Why? |
| Equipment Contamination | 2 | 2017 | 1308 | 0.18 | Why? |
| Oxidative Stress | 3 | 2018 | 2050 | 0.18 | Why? |
| Aged | 35 | 2021 | 215776 | 0.17 | Why? |
| Injections, Epidural | 1 | 2017 | 45 | 0.17 | Why? |
| Myocardial Infarction | 3 | 2018 | 3361 | 0.17 | Why? |
| Marital Status | 1 | 2017 | 186 | 0.17 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.17 | Why? |
| Blood Flow Velocity | 1 | 2018 | 193 | 0.16 | Why? |
| Middle Aged | 37 | 2021 | 270681 | 0.16 | Why? |
| Male | 42 | 2021 | 367725 | 0.16 | Why? |
| Equipment Failure | 1 | 2018 | 197 | 0.16 | Why? |
| Female | 42 | 2021 | 380317 | 0.16 | Why? |
| Prostheses and Implants | 1 | 2017 | 116 | 0.16 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2017 | 113 | 0.16 | Why? |
| Nebivolol | 1 | 2015 | 12 | 0.16 | Why? |
| Hydrodynamics | 1 | 2017 | 177 | 0.15 | Why? |
| Vasomotor System | 1 | 2015 | 13 | 0.15 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.15 | Why? |
| Apolipoprotein L1 | 1 | 2017 | 161 | 0.15 | Why? |
| Lysophospholipids | 1 | 2016 | 74 | 0.15 | Why? |
| Cysteine | 1 | 2017 | 238 | 0.15 | Why? |
| Obesity, Abdominal | 1 | 2017 | 167 | 0.15 | Why? |
| Metoprolol | 1 | 2015 | 42 | 0.15 | Why? |
| Myocardial Revascularization | 1 | 2018 | 267 | 0.15 | Why? |
| Sphingosine | 1 | 2016 | 101 | 0.15 | Why? |
| Glutathione | 1 | 2017 | 280 | 0.15 | Why? |
| Risk Factors | 19 | 2021 | 71621 | 0.15 | Why? |
| Arteries | 1 | 2017 | 283 | 0.14 | Why? |
| Respiratory Insufficiency | 3 | 2021 | 7301 | 0.14 | Why? |
| Surface Plasmon Resonance | 1 | 2017 | 440 | 0.14 | Why? |
| Device Removal | 1 | 2017 | 221 | 0.14 | Why? |
| Cardiac Catheterization | 3 | 2017 | 882 | 0.14 | Why? |
| Critical Illness | 5 | 2021 | 17281 | 0.14 | Why? |
| United States | 13 | 2021 | 46150 | 0.14 | Why? |
| Surgery, Computer-Assisted | 1 | 2017 | 183 | 0.14 | Why? |
| Hematopoietic Stem Cells | 1 | 2017 | 321 | 0.14 | Why? |
| Biomarkers | 13 | 2021 | 23361 | 0.14 | Why? |
| Low Back Pain | 1 | 2017 | 190 | 0.14 | Why? |
| Coronary Stenosis | 1 | 2018 | 273 | 0.14 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.13 | Why? |
| Professional-Family Relations | 1 | 2019 | 424 | 0.13 | Why? |
| Vascular Stiffness | 1 | 2017 | 264 | 0.13 | Why? |
| Regeneration | 1 | 2017 | 429 | 0.13 | Why? |
| Renal Replacement Therapy | 2 | 2020 | 1530 | 0.13 | Why? |
| Survival Rate | 5 | 2021 | 9206 | 0.13 | Why? |
| Coronary Angiography | 3 | 2018 | 2275 | 0.13 | Why? |
| Humans | 58 | 2021 | 930598 | 0.13 | Why? |
| Patient Positioning | 2 | 2021 | 1505 | 0.13 | Why? |
| Stroke Volume | 3 | 2018 | 2153 | 0.13 | Why? |
| Incidence | 10 | 2021 | 25622 | 0.13 | Why? |
| Diffusion of Innovation | 1 | 2017 | 440 | 0.13 | Why? |
| Diabetic Nephropathies | 1 | 2017 | 315 | 0.13 | Why? |
| Atrial Fibrillation | 2 | 2018 | 2320 | 0.13 | Why? |
| Echocardiography, Three-Dimensional | 1 | 2014 | 135 | 0.13 | Why? |
| Vasodilation | 1 | 2015 | 258 | 0.13 | Why? |
| Causality | 1 | 2017 | 857 | 0.12 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.12 | Why? |
| Aged, 80 and over | 16 | 2021 | 88759 | 0.12 | Why? |
| Prone Position | 2 | 2021 | 1861 | 0.12 | Why? |
| Predictive Value of Tests | 5 | 2018 | 9537 | 0.12 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.12 | Why? |
| Pain | 2 | 2017 | 1084 | 0.11 | Why? |
| Nerve Compression Syndromes | 1 | 2011 | 25 | 0.11 | Why? |
| Antidepressive Agents | 1 | 2016 | 509 | 0.11 | Why? |
| Registries | 4 | 2021 | 12327 | 0.11 | Why? |
| Aortic Valve | 1 | 2018 | 664 | 0.11 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.11 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.11 | Why? |
| Peripheral Arterial Disease | 1 | 2017 | 471 | 0.11 | Why? |
| Proportional Hazards Models | 6 | 2021 | 6543 | 0.11 | Why? |
| Follow-Up Studies | 9 | 2020 | 17020 | 0.11 | Why? |
| Mitral Valve | 1 | 2014 | 342 | 0.11 | Why? |
| Precision Medicine | 2 | 2017 | 1477 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.10 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.10 | Why? |
| Pyrimidines | 1 | 2018 | 1557 | 0.10 | Why? |
| Acute Kidney Injury | 2 | 2020 | 5762 | 0.10 | Why? |
| Mitral Valve Insufficiency | 1 | 2014 | 302 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.10 | Why? |
| Time Factors | 8 | 2021 | 31397 | 0.10 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 66 | 0.09 | Why? |
| Nitric Oxide | 1 | 2015 | 769 | 0.09 | Why? |
| Postoperative Complications | 2 | 2017 | 5861 | 0.09 | Why? |
| Receptors, CXCR4 | 2 | 2018 | 83 | 0.09 | Why? |
| Antigens, CD34 | 2 | 2018 | 125 | 0.09 | Why? |
| Pain Measurement | 1 | 2011 | 533 | 0.09 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.09 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.09 | Why? |
| Pyrazoles | 1 | 2018 | 1791 | 0.09 | Why? |
| Prognosis | 7 | 2021 | 32490 | 0.09 | Why? |
| Adult | 18 | 2021 | 244371 | 0.08 | Why? |
| Blood Coagulation Disorders | 1 | 2021 | 2040 | 0.08 | Why? |
| Pulse Wave Analysis | 2 | 2018 | 221 | 0.08 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.08 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.08 | Why? |
| Hypoxia | 1 | 2021 | 3626 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Guidelines as Topic | 2 | 2017 | 2844 | 0.08 | Why? |
| Inpatients | 1 | 2021 | 5161 | 0.07 | Why? |
| Organ Transplantation | 1 | 2020 | 2616 | 0.07 | Why? |
| Neurosurgical Procedures | 1 | 2017 | 1738 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Cause of Death | 4 | 2021 | 4823 | 0.07 | Why? |
| Curriculum | 1 | 2018 | 3083 | 0.07 | Why? |
| Patient Admission | 1 | 2021 | 5250 | 0.07 | Why? |
| Practice Guidelines as Topic | 2 | 2020 | 15421 | 0.07 | Why? |
| Acute Coronary Syndrome | 1 | 2018 | 2107 | 0.07 | Why? |
| Chi-Square Distribution | 2 | 2017 | 961 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.06 | Why? |
| Health Status | 1 | 2016 | 3259 | 0.06 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.06 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.06 | Why? |
| Phenotype | 3 | 2017 | 4037 | 0.06 | Why? |
| Comorbidity | 4 | 2021 | 34796 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Retrospective Studies | 9 | 2018 | 105322 | 0.06 | Why? |
| Aging | 1 | 2018 | 3581 | 0.06 | Why? |
| Odds Ratio | 3 | 2017 | 5861 | 0.05 | Why? |
| Trigger Points | 1 | 2020 | 38 | 0.05 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.05 | Why? |
| Injections, Intra-Articular | 1 | 2020 | 104 | 0.05 | Why? |
| Heart Valve Prosthesis | 2 | 2018 | 533 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.05 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.05 | Why? |
| Injections | 1 | 2020 | 237 | 0.05 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.05 | Why? |
| AC133 Antigen | 1 | 2018 | 19 | 0.05 | Why? |
| Logistic Models | 3 | 2020 | 9089 | 0.05 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.05 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.05 | Why? |
| Flow Cytometry | 2 | 2018 | 2393 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.05 | Why? |
| Substance Withdrawal Syndrome | 1 | 2020 | 137 | 0.05 | Why? |
| fms-Like Tyrosine Kinase 3 | 1 | 2018 | 43 | 0.05 | Why? |
| Sex Factors | 2 | 2017 | 11014 | 0.05 | Why? |
| Ventricular Function, Left | 2 | 2018 | 1555 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.04 | Why? |
| Body Fat Distribution | 1 | 2017 | 25 | 0.04 | Why? |
| Immunoenzyme Techniques | 1 | 2020 | 448 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Mice | 1 | 2017 | 21357 | 0.04 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2018 | 211 | 0.04 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.04 | Why? |
| Early Medical Intervention | 1 | 2021 | 487 | 0.04 | Why? |
| Recovery of Function | 2 | 2018 | 2461 | 0.04 | Why? |
| Absorptiometry, Photon | 1 | 2017 | 168 | 0.04 | Why? |
| Military Medicine | 1 | 2020 | 211 | 0.04 | Why? |
| Michigan | 1 | 2021 | 988 | 0.04 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.04 | Why? |
| Lymphoma, B-Cell | 1 | 2018 | 166 | 0.04 | Why? |
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 98 | 0.04 | Why? |
| United States Department of Veterans Affairs | 1 | 2020 | 553 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Muscle Hypotonia | 1 | 2015 | 16 | 0.04 | Why? |
| Death, Sudden, Cardiac | 1 | 2021 | 522 | 0.04 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.04 | Why? |
| Menopause | 1 | 2017 | 136 | 0.04 | Why? |
| Plethysmography | 1 | 2015 | 30 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Forearm | 1 | 2015 | 52 | 0.04 | Why? |
| Estradiol | 1 | 2017 | 250 | 0.04 | Why? |
| Adenine | 1 | 2018 | 463 | 0.04 | Why? |
| Spinal Cord | 1 | 2017 | 281 | 0.04 | Why? |
| American Heart Association | 1 | 2017 | 347 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.04 | Why? |
| Aorta | 1 | 2018 | 355 | 0.04 | Why? |
| Regional Blood Flow | 1 | 2015 | 172 | 0.04 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.03 | Why? |
| Disease Progression | 3 | 2018 | 13580 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2021 | 1475 | 0.03 | Why? |
| Hypertension | 1 | 2015 | 8895 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.03 | Why? |
| Bioprosthesis | 1 | 2014 | 126 | 0.03 | Why? |
| Prosthesis Failure | 1 | 2014 | 195 | 0.03 | Why? |
| Receptors, Interleukin-6 | 1 | 2021 | 1383 | 0.03 | Why? |
| Non-ST Elevated Myocardial Infarction | 1 | 2018 | 490 | 0.03 | Why? |
| Appointments and Schedules | 1 | 2020 | 1204 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2015 | 867 | 0.03 | Why? |
| Piperidines | 1 | 2018 | 795 | 0.03 | Why? |
| Femoral Nerve | 1 | 2011 | 14 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Testosterone | 1 | 2017 | 596 | 0.03 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.03 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.03 | Why? |
| Femoral Neuropathy | 1 | 2011 | 18 | 0.03 | Why? |
| Personnel Staffing and Scheduling | 1 | 2020 | 1578 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.03 | Why? |
| Advisory Committees | 1 | 2017 | 1418 | 0.03 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Safety | 1 | 2017 | 1583 | 0.02 | Why? |
| Thrombophilia | 1 | 2021 | 1935 | 0.02 | Why? |
| Hemorrhage | 1 | 2021 | 3013 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Animals | 1 | 2017 | 78931 | 0.02 | Why? |
| Disinfection | 1 | 2020 | 2912 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Blood Glucose | 1 | 2020 | 3642 | 0.02 | Why? |
| Myocardium | 1 | 2018 | 2323 | 0.02 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2017 | 10083 | 0.02 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.02 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Double-Blind Method | 1 | 2015 | 5988 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.01 | Why? |
| Travel | 1 | 2021 | 7220 | 0.01 | Why? |
| Germany | 1 | 2017 | 9196 | 0.01 | Why? |
| ST Elevation Myocardial Infarction | 1 | 2018 | 3051 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Magnetic Resonance Imaging | 1 | 2017 | 6551 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |